ﺮﻴﮔاو ﺮﻴﻏ 1 ﻲﺴﻳﻮﻧ ﻪﻪﻟﺎﻘﻣ هﺎﮔرﺎﻛ · oning according to...
TRANSCRIPT
يه ازبيماريهاي غير واگير
نويسي 1ه نويسي 1ه[email protected]ائي[email protected]ائي
پژوهشكده پيشگيري اولي
مقاله كارگاه مقالهكارگاهسبزقبا عليمحمد مير دكتر مير عليمحمد سبزقبادكتر
چرا مقاله مينويسيم؟
پزشكي:اه مقاالت علمي تحقيقاتي:مخاطب)1(نگارش مراكز پژوهشي كارشناسان كارشناسان پژوهشي مراكز تحقيقاتي :مخاطب)1(نگارش علمي مقاالت پزشكي: اه)يك روز(ساعت 5 :مدت زمان كارگاه نفر 12 :ظرفيت كارگاه
سالن كتابخانه الكترونيكي دانشكده پزشكي :محل برگزاري پيشگيري اوليه از بيماريهاي غير واگير دكتر شيرين سادات بدري ، دكتر شاه ثنائي و دكتر مير عليمحمد سبزقبائي :مدرسين23/11/1393پنج شنبه :ان برگزاري
مدرسدكتر سبزقبائي
دكتر بدريدكتر سبزقبائييدكتر سبزقبائي ب بز ردكتر سبزقبائيدكتر شاه ثنائي
-دكتر شاه ثنائيدكتر سبزقبائي
دكتر بدريدكتر سبزقبائيندگان
بدري دكتر بدريدكترهمه مدرسين
كارگا نام كارگانام
پژوهشكده :برگزار كننده زما
عنوانفافتتاحيه كارگاه
انواع مقاالت علمينحوه صحيح نگارش يك پاراگراف استاندارد
انتخاب عنوان:آموزش قدم به قدم م ب م نوزش و بنگارش مقدمه دستنوشته : آموزش قدم به قدمنگارش استاندارد روش شناسي دستنوشته: آموزش قدم به قدم
ا ا ا پذيرائي و استراحتذنگارش نتايج دستنوشته: آموزش قدم به قدمنگارش بحث و نتيجه گيري دستنوشته:آموزش قدم به قدمنگارش رفرانسهاي دستنوشته: آموزش قدم به قدمنگارش تشكرو قدرداني ، تعارض منافع و نحوه مشاركت نويسن: آموزش قدم به قدمقدم به قدم عنوان:آموزش انتخاب و دستنوشته خالصه ش نگا نگارش خالصه دستنوشته و انتخاب عنوان:آموزش قدم به قدم
پرسش و پاسخ و تبادل نظر شركت كنندگان
اصل اساسي: ، شفاف، ساده
ال خالصه
اف اگ ا ن چگونه پاراگرافگبنويسيم؟
وFactيان كننده يك ونآنحواشي مرتبط با
.د بحث را بازگو كنيد
. شما را تقويت و حمايت ميكند. صادقانه ، بي طرفانه و بدون تورش بصورت مستند بيان كنيد
كنيد بيان مخالفين نظريه به نسبت .صفانه نسبت به نظريه مخالفين بيان كنيد.صفانه. كنيد
مشكل يا موقعيت)fact (موردد كن ان ب را و خودتان موضع اف اگ ا ن .موضع خودتان و را بيان كنيدگشواهدي ارائه كنيد كه جايگاه
چگونه پاراگرافبنويسيم؟
نظر مخالفان با نظر خودتان رامنص انتقاد در را خودتان داليل خودتان را در انتقاد منصداليلنتيجه كلي را در جمله آخر قيد
:كارگروهي
اف اگ ا ك تنظيم يك پاراگرافظنقد وضعيت
فات ا موجود در تصادفاتتجاده اي
Intro: Present the problem or
it ti
المت در ر
situation.
Take a stand!
ظامي و ده
Reason #1 for positionpo
ints.
گونه آمار
Reason #2 for position
denc
e for
all
3 p تمين
يرسدReason #3 for position
Ev
id چنين كشور
Present a logicalsolution.
Recap the staff stance.
زمينه واهد
سالدر وقايعترينتاثيرگزارجملهازايجاده حوادثكشو مردم درصد12 از بيش مرگ دليل .است ايرانيان
آ انتظنيرويآماراساسبر.استرانندگيتصادفات اثرافتا اتفاق جرحي تصادف يك دقيقه سه هر ما كشور دراينگاثر برراخودجاننفريكدقيقهبيست هر در
طبق بر كه درحاليست اين .ميدهد دست از تصادفاتهفتبعنوانايجادهسوانحبدليلمرگاحتمال جهانيمي بنظر .ميگردد محسوب باختن جان احتمالي دليل
اا همچو رانندگيزماندررانندگانرفتارو نحوه تغييرك تردد پر هاي جاده و نقليه وسائط سازي ايمن
ا ذا اگاا زايندر درنگهرگونهوداشتهناپذيراجتناب ضرورتيخو بعدي جبران قابل غير و ناگوار پيامدهاي ساز سبب .بود
h // hhttp://www.theesaurus.com
نگارش عنوان مقالهيتحقيقاتي ي
“Reaction of a bidentate ligands (4,4dimethyl 2,2′‐bipyridine) with planary , py ) pchloro‐bridged ruthenium: Synthesisdicarbonyl[4,4′‐dimethyl‐2,2′‐bipyridκO1,κO2]{2‐[tricarbonyl(η6‐phenyleκC1)chromium]pyridine‐κN}rutheniuh fl h h t ”hexafluorophosphate”
A descriptive‐analytic research for p ycomparison between two cohort of school‐age students with obsessive‐compulsive disorder in a rural non‐fojunior high school in Shahrekord cityA two year studyA two‐year study
4′‐r‐chirals of cis‐dine‐ne‐um
Iranian
or profit y in Iran:
عنوان مقاله تحقيقاتياجد متغير هاي اصلي مورد بررسي
)مات كليدي مقالهوعمشخص كننده نوع مطالعه ص
Running titleعنوان تكرار ،
مقاله داراي كمترين استناد در 2
در عنوان: و داشتن)كاراكتر200 ازبيمارستان ، كشور تحقيقساليا، انجام انجام تحقيق ساليا ، كشور ، بيمارستان
Jacques TS, Sebire NJ. The impact of article titles oanalysis of general and specialist medical journals.y g p jSociety of Medicine Short Reports 2009, 1(2), 1–5.
250مقاله داراي باالترين استناد و 250مقايسه
كمتر(طول عنوان :عوامل افزايش دهنده استناداستناد دهنده كاهش نام:عوامل از شهراستفاده شهراستفاده از نام:عوامل كاهش دهنده استناد
on citation hits: an Journal of the Royal y.
ground: Psychiatric consultation is necessary for all pground: Psychiatric consultation is necessary for all poning and its reliability depends on the proper functiormance. This study aimed to determine the possiblee TCAs' poisoninge TCAs poisoning.
erials and Methods: In this cross‐sectional study, patoning were allocated to two groups of severe poisoni
h h i h i d id QRS lac arrhythmias, hypotension, and wide QRS complexoning according to their clinical presentation at the tents underwent memory performance test both imminitial conscio sness after admission sing Wechsleinitial consciousness after admission, using Wechsle
lts: During the study period, sixty seven TCA‐poisonee evaluated, of which 67.2% were female. The mean ediately and 24 hours after the initial consciousness respectively (P<0.001). At the time of initial conscio
mory score had statistically significant correlation withnty four hours after the initial consciousness, memorelated with the amount of ingested drug and the into
clusion: Following the recovery from somatic symptoclusion: Following the recovery from somatic symptoents may still suffer from memory impairment and it ble for performing a reliable psychiatric consultation
patients with intentionalpatients with intentional on of patients' memory e memory impairment following
tients with acute TCAs ing (with coma, seizures, ) d ild dx) and mild to moderate ime of hospital admission. All
mediately and 24 hours after er Memor Scale (WMS IV)er Memory Scale (WMS‐IV).
ed patients (aged, 20‐64 years) memory scores of patients y pwere 31.43 ± 9.02 and 50.62 ±ousness after admission, h the amount of TCAs ingested. ry score was also statistically oxication severity.
oms of acute TCA poisoningoms of acute TCA poisoning, seems that this time is not n.
ground:Midazolam is commonly and safely used in poground: Midazolam is commonly and safely used in ponsive care for the control of the agitated poisoned patier and safer antidepressants, tricyclic antidepressants in many countries due to their cost‐effectiveness. Sevin many countries due to their cost effectiveness. Sevciated with these drugs arises largely from their well‐dity. In this study we aimed to investigate the probable odynamic indices in TCA poisoned patients.
hods: In this clinical study we have evaluated some cares of 200 TCA poisoned patients whom were randomlazolam with a first loading dose of 0 1mg / kg (2 mg /mazolam with a first loading dose of 0.1mg / kg (2 mg /mtenance infusion of 0.1mg /kg /h of the drug in dextro0.33% of NaCl) or placebo (dextrose‐saline infusion wilic/diastolic blood pressure, respiratory rate, neurologc/d as o c b ood p essu e, esp a o y a e, eu o ogapy were recorded at the time of admission and hourly
lts: There was a statistically significant reduction in thed group after the first hour of hospital admission Thed group after the first hour of hospital admission. Thrences in the respiratory rate, central nervous system es between the two groups.
lusion: Midazolam may reduce tachycardia (and its faof admission in TCA poisoned patients.
oisoning management andoisoning management and ents. Despite the introduction of (TCA) are still prescribed and vere morbidity and mortalityvere morbidity and mortality documented cardiovascular effect of Midazolam on some
rdiovascular and hemodynamic y allocated for receiving min ) followed by a 6‐hoursmin.) followed by a 6 hours ose‐saline (3.33% of dextrose thout Midazolam). Pulse rate, gic status and the outcome of g c s a us a d e ou co e oy for the next 6 hours.
e heart rate of the Midazolamere were no significantere were no significant manifestations and other
tal consequences) in the first
رنگارش عنوان تكرار مقالهه ر ن و رش
k factors and the outcome of therapyk factors and the outcome of therapyzure after carbamazepine poisoning: tional studytional study
y in patients withy in patients with a two year cross‐
ect of intravenous Midazolam on cardect of intravenous Midazolam on cardte tricyclic antidepressants poisoninguble blind clinical trialuble blind clinical trial
diac parameters indiac parameters in g: a randimised
ژنگارش كليد واژه مقاله و رش
كلمات كليدي
ground: Psychiatric consultation is necessary for all pground: Psychiatric consultation is necessary for all poning and its reliability depends on the proper functiormance. This study aimed to determine the possiblee TCAs' poisoninge TCAs poisoning.
erials and Methods: In this cross‐sectional study, patoning were allocated to two groups of severe poisoni
h h i h i d id QRS lac arrhythmias, hypotension, and wide QRS complexoning according to their clinical presentation at the tents underwent memory performance test both imminitial conscio sness after admission sing Wechsleinitial consciousness after admission, using Wechsle
lts: During the study period, sixty seven TCA‐poisonee evaluated, of which 67.2% were female. The mean ediately and 24 hours after the initial consciousness respectively (P<0.001). At the time of initial conscio
mory score had statistically significant correlation withnty four hours after the initial consciousness, memorelated with the amount of ingested drug and the into
clusion: Following the recovery from somatic symptoclusion: Following the recovery from somatic symptoents may still suffer from memory impairment and it ble for performing a reliable psychiatric consultation
patients with intentionalpatients with intentional on of patients' memory e memory impairment following
tients with acute TCAs ing (with coma, seizures, ) d ild dx) and mild to moderate ime of hospital admission. All
mediately and 24 hours after er Memor Scale (WMS IV)er Memory Scale (WMS‐IV).
ed patients (aged, 20‐64 years) memory scores of patients y pwere 31.43 ± 9.02 and 50.62 ±ousness after admission, h the amount of TCAs ingested. ry score was also statistically oxication severity.
oms of acute TCA poisoningoms of acute TCA poisoning, seems that this time is not n.
ground:Midazolam is commonly and safely used in poground: Midazolam is commonly and safely used in ponsive care for the control of the agitated poisoned patier and safer antidepressants, tricyclic antidepressants in many countries due to their cost‐effectiveness. Sevin many countries due to their cost effectiveness. Sevciated with these drugs arises largely from their well‐dity. In this study we aimed to investigate the probable odynamic indices in TCA poisoned patients.
hods: In this clinical study we have evaluated some cares of 200 TCA poisoned patients whom were randomlazolam with a first loading dose of 0 1mg / kg (2 mg /mazolam with a first loading dose of 0.1mg / kg (2 mg /mtenance infusion of 0.1mg /kg /h of the drug in dextro0.33% of NaCl) or placebo (dextrose‐saline infusion wilic/diastolic blood pressure, respiratory rate, neurologc/d as o c b ood p essu e, esp a o y a e, eu o ogapy were recorded at the time of admission and hourly
lts: There was a statistically significant reduction in thed group after the first hour of hospital admission Thed group after the first hour of hospital admission. Thrences in the respiratory rate, central nervous system es between the two groups.
lusion: Midazolam may reduce tachycardia (and its faof admission in TCA poisoned patients.
oisoning management andoisoning management and ents. Despite the introduction of (TCA) are still prescribed and vere morbidity and mortalityvere morbidity and mortality documented cardiovascular effect of Midazolam on some
rdiovascular and hemodynamic y allocated for receiving min ) followed by a 6‐hoursmin.) followed by a 6 hours ose‐saline (3.33% of dextrose thout Midazolam). Pulse rate, gic status and the outcome of g c s a us a d e ou co e oy for the next 6 hours.
e heart rate of the Midazolamere were no significantere were no significant manifestations and other
tal consequences) in the first
ينگارش وابستگي سازمانييي ز ي ب و رش
گانوابستگي سازماني چند قسمت است.
Department of Poisoning Emergencies, Noor University g , yhospital, Isfahan University of Medical Sciences, Isfahan, Iran
نام و وابستگي سازماني نويسندگاسامينحوه خالصه كردن اساميق ا ل فا ا ا اسامي و فاميلهاي چند قسمتي
k factors and the outcome of therapyk factors and the outcome of therapyzure after carbamazepine poisoning: tional studytional studyram Yaraghi1, Marzieh Salehi3, Gholamreza Massoumdi Mirhosseini4, Sayed Kazem Alavi‐Naeini2,3
partment of Anesthesiology and Critical Care, School edical Sciences, Isfahan, Iran
ical Toxicology Research Center, Isfahan University o
partment of Anesthesia, Faculty of Medicine, Isfahanan Iranan, Iran
partment of Clinical Toxicology, Noor and Ali Asghar [an University of Medical Sciences, Isfahan, Iran
ulty of Health Sciences, University of Zenica, Zenica,
y in patients withy in patients with a two year cross‐
mi1, Lejla Zunic5, Mohammad
of Medicine, Isfahan University
f Medical Sciences, Isfahan, Iran
University of Medical Sciences,
[PBUH] University hospital,
Bosnia and Herzegovina1
آناتومي يك مقاله علمي
رشنگارش مقدمه مقاله
مقدمه ميخواهيم بگوئيم كه چرا كار ما ضرورت
د؟ دا و تازگي دارد؟تازگ400 پنج يا شش پاراگراف(كلمه 500تا(تدوين الگوي مقدمه از كليات به جزئياتهاي اژه د كل خالصه ا ب ح ض ت توضيح بسيار خالصه كليد واژه هاي
عنوان مقالهط ت ه خال مرور متون بصورت خالصه و مرتبطCopy pasteنكنيد!آخرين جمالت بالفاصله قبل از روش
:كار گروهي:زير طراحي كنيد ي ي ر زيرفس كوهي درريه سرطان ريهسرطان
كزيك الگوي مقدمه براي موضوع ز وع و ي بر وي يبررسي اثر عصاره الكلي كرفس درمان سدرمان
رطان ريه در جهان و تغيير كيفيت زندگي
كيد بر محاسن و معايب آنهاآ
و همچنين سرطان ريهطا
اشد ث ه شا هاي طان ان د د ت در درمان سرطان هاي مشابه موثر باشدت
آمار مرگ بدليل سرطان در جهان و آمار مرگ بدليل سر•
مهمترين روش هاي شيمي درماني رايج سرطان ريه با تاك•
ا گ ا ا روش هاي جايگزين شيمي درماني•
ا طا ا ا گ ا ا ا فا ا ا سوابق استفاده از داروهاي گياهي در درمان سرطان ها و•
آ• ان ف ا ه خال ك ف ك ا گ ف معرفي گياه كرفس كوهي و خالصه مصارف درماني آن•
ت• ا كن ه ك ف ك دهد نشان كه اهدي ش ط طرح شواهدي كه نشان ميدهد كرفس كوهي ممكن است•
هش• پژ ال سئ ح ط طرح سئوال پژوهشي•
بنگارش بحث مقاله رش
محدوديت هاي مطالعه ديگران و نقاط قوتد خ ه مطالعه خودطال
نقاط ضعف مطالعه خود را ذكر كنيد نتيجه نهائي و كاربردي خود را بدون اشاره به
)با زمان حال. (اعداد و ارقام بيان كنيد اين نتيجه نهائي بايد حاصل از همين عنوان
!مقاله باشد فقط وقتي توصيه به مطالعه بيشتر بكنيد كه
!الزم باشد ب زم
)و نتيجه گيري(بحث كلمه 1000: حدود يك سوم مقالهمقدمه را تكرار نكنيد!بدهيد پاسخ مقدمه انتهاي سئوال به سئوال انتهاي مقدمه پاسخ بدهيدبه تمامي نتايج جزء به جزء بايد مورد بحث قرار
ند .گيرندگ اين نتايج را با مطالعات مشابه با عدد مقايسه
د . كنيدكنداليل احتمالي تفاوت نتايج را بنويسيد.
رنگارش تقدير و تشكررر و ر رش
ACKNOW
study is the result of a Doctor of Medicine thesch was financially supported by the vice chancelch was financially supported by the vice‐chancelarch and technology of the Isfahan University ofnces. Authors would like to thank Dr. Farzad Ghekind co‐operation during the study period and Dchson for her help in English editing. Authors woare that some parts of this study (which was theare that some parts of this study (which was thepreliminary data analysis) is previously publishednal in Farsi language (Journal of Isfahan Medicalthis article is published with the permission of tnal's authorities and the publisher, which are henowledgednowledged.
WLEDGEMENTSتقدير و تشكر
is project lery for كساني كه شرايط نويسندگيlery for f Medical eshlaghi for
ي وي ي ر ينداشته اند
r. Kimberly ould like to e result of
كساني كه اسمشان در اينe result of d in a local School)
!قسمت مي آيد بايد راضي باشندthat ereby تشكر از پشتيبانان مالي
ACKNOW
“This work was financially suppoth i h ll f hthe vice chancellery for research technology of the Isfahan Universmedical Sciences [grant number xmedical Sciences [grant number x
“This research received no speciffrom any funding agency in the pcommercial, or not‐for‐profit sec
Authors would like to thank all personnel of the coronary care utheir sincere help and support
WLEDGEMENTSتقدير و تشكر
rted by d
كساني كه شرايط نويسندگيا andاش
sity of xxxx] ”
نداشته اند كساني كه اسمشان در اينxxxx].
fic grant
ن ن ي!قسمت مي آيد بايد راضي باشند
مال انان پشت از ,publicتشكرtors.”
تشكر از پشتيبانان مالي
nit for
عنگارش تعارضات منافععع ر رش
Authors declared no conflict of in
عدم تعارض منافع
nterests خصوصا در مورد منابع مالي
نگان وينگارش مشاركت نويسندگ ر رش
AUTHORS? ?AUTHORS مقاله چه كسي است؟ ؟ ي چ وينويسنده
Intelectual(انجام فعاليت علمي تخصصي : اساسي
ي:ف انجمن بين المللي سردبيران ژورنالهاي علمي ي ه ژور ن ر ر ي ن نمشاركت در ارائه ايده ، جمع آوري تخصصي داده يا آناليز
ل ال ا ا قال ن ش ش نگا ك شاركت در نگارش پيش نويس مقاله يا اصالح علميشاطالعه و تائيد مقاله قبل از ارسال به ژورنال
؟؟؟ خ ها ت هاي خصوصي؟؟؟ت
اصل
تعريف
AUTHORS?
ر مش مشمط
A significantcontribution to
( ) Th t d t d d i d t
كت ش
(a) The study concept and design or data collection, or analysis and interpretation of data;
AND (b) drafting/revising the manuscript for important intellectual content; and
شركتAND (c) approval of the final version to bepublished
AUTHORS' CONTR
Authors' contribution:
AY, NEM, AMS and MK contributedesigning and conducting the stug g gcollected the data. MH, SMMH ahelp in data analysis. SF recheckestatistical analysis and prepared tmanuscript. All authors have assipreparation of the man script anpreparation of the manuscript anread and approved the content omanuscript and are accountablemanuscript and are accountable aspects of the work.
RIBUTIONمشاركت نويسندگان
حتما بايد شرايط نويسندگي موردگ ا ق ا
ed in udy. MK
.رعايت قرار گيردy
nd EB ed the the isted in nd ha end have of the for allfor all
Email: [email protected]